New-onset atrial fibrillation following percutaneous closure of patent foramen ovale: a systematic review and meta-analysis

2021 ◽  
Author(s):  
Laura Oliva ◽  
Ella Huszti ◽  
Madeleine Barker ◽  
Claudia Frankfurter ◽  
Ruth Hall ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Systematic Review ◽  
Patent Foramen Ovale ◽  
Meta Analysis ◽  
Percutaneous Closure ◽  
Foramen Ovale ◽  
Onset Atrial Fibrillation ◽  
New Onset

New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials

2019 ◽  
Vol 14 (17) ◽  
pp. 1788-1790 ◽  
Author(s):  
Akram Y. Elgendy ◽  
Islam Y. Elgendy ◽  
Mohammad K. Mojadidi ◽  
Ahmed N. Mahmoud ◽  
Julia S. Barry ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Systematic Review ◽  
Patent Foramen Ovale ◽  
Meta Analysis ◽  
Foramen Ovale ◽  
Randomised Trials ◽  
Onset Atrial Fibrillation ◽  
New Onset

Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis

Heart ◽  
2013 ◽  
Vol 100 (5) ◽  
pp. 389-395 ◽  
Author(s):  
Mathias Wolfrum ◽  
Georg M Froehlich ◽  
Guido Knapp ◽  
Leanne K Casaubon ◽  
James J DiNicolantonio ◽  
...  
Keyword(s):  
Systematic Review ◽  
Stroke Prevention ◽  
Patent Foramen Ovale ◽  
Meta Analysis ◽  
Percutaneous Closure ◽  
Foramen Ovale

Is caffeine or coffee consumption a risk for new-onset atrial fibrillation? A systematic review and meta-analysis

2020 ◽  
pp. 204748732090838 ◽  
Author(s):  
Chayakrit Krittanawong ◽  
Anusith Tunhasiriwet ◽  
Zhen Wang ◽  
Ann M Farrell ◽  
Sakkarin Chirapongsathorn ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Systematic Review ◽  
Meta Analysis ◽  
Coffee Consumption ◽  
Onset Atrial Fibrillation ◽  
New Onset

scholarly journals Atrial Fibrillation Following Patent Foramen Ovale Closure

Stroke ◽  
2021 ◽  
Vol 52 (5) ◽  
pp. 1653-1661
Author(s):  
Jessie Ze-Jun Chen ◽  
Vincent N. Thijs
Keyword(s):  
Atrial Fibrillation ◽  
Patent Foramen Ovale ◽  
Stroke Risk ◽  
Meta Analysis ◽  
Percutaneous Closure ◽  
Foramen Ovale ◽  
Stroke Risk Factor ◽  
Increased Risk ◽  
Pfo Closure

Background and Purpose: Multiple studies evaluated whether patent foramen ovale (PFO) closure reduces the risk of ischemic stroke. One commonly reported complication of PFO closure is the development of atrial fibrillation (AF), which is itself a powerful stroke risk factor that requires specific management. This study aims to evaluate the frequency of AF in patients post-percutaneous closure of PFO and the clinical factors that predict AF detection. Methods: Studies were identified by systematically searching EMBASE and MEDLINE databases on July 11, 2019. Meta-analysis of proportions was performed, assuming a random-effects model. Results: A total of 6 randomized controlled trials and 26 observational studies were included, comprising 3737 and 9126 patients, respectively. After PFO closure, the rate of AF development was 3.7 patients per 100 patient-years of follow-up (95% CI, 2.6–4.9). The risk of AF development is concentrated in the first 45 days post-procedure (27.2 patients per 100 patient-years [95% CI, 20.1–34.81], compared with 1.3 patients per 100 patient-years [95% CI, 0.3–2.7]) after 45 days. Meta-regression by age suggested that studies with older patients reported higher rate of AF ( P =0.001). In medically treated patients, the rate of AF development was 0.1 per 100 patient-years of follow-up (95% CI, 0.0–0.4). Closure of PFO is associated with increased risk of AF compared with medical management (odds ratio, 5.3 [95% CI, 2.5–11.41]; P <0.001). Conclusions: AF is more common in PFO patients who had percutaneous closure compared with those who were medically treated. The risk of AF was higher in the first 45 days post-closure and in studies that included patients with increased age.

Sign in / Sign up

Export Citation Format

Share Document